Thrombosis and Haemostasis, Inhaltsverzeichnis Thromb Haemost 1986; 56(03): 260-262DOI: 10.1055/s-0038-1661662 Original Article Schattauer GmbH Stuttgart Interaction of Vasopressin with Human Blood Platelets: Dependency on Mg2+ Autoren Institutsangaben Isabella Roos The Department of Research, Kantonsspital Basel, Switzerland Fabrizia Ferracin The Department of Research, Kantonsspital Basel, Switzerland Alfred Pletscher The Department of Research, Kantonsspital Basel, Switzerland Artikel empfehlen Abstract als PDF herunterladen(opens in new window) Artikel einzeln kaufen(opens in new window) Summary Arginine-vasopressin (AVP) in the presence of Mg2+ but not in the absence of bivalent cations led to accumulation of [32P]-phosphatidic acid ([32P]-PA) in human blood platelets. Mg2+ also enhanced the specific binding of [3H]-AVP to intact platelets. The concentrations of the cation which enabled AVP to cause half maximal rise of [32P]-PA and those inducing half maximal [3H]-AVP-binding were of the same order. It is concluded that the stimulation of phosphatidyl inositide breakdown by AVP in presence of Mg2+ is at least partially due to a Mg2+-induced enhancement of specific AVP-binding to the platelet membranes. Key words Key wordsBlood platelets of man - Arginine-vasopressin - Phos-phoinositide turnover: dependence on Mg2+ - Magnesium ions - Vasopressin binding: dependence on Mg2+ PDF (1926 kb) Referenzen References 1 Siess W, Stifel M, Binder H, Weber PC. Activation of Vrreceptors by vasopressin stimulates inositol phospholipid hydrolysis and arachido-nate metabolism in human platelets. Biochem J 1986; 233: 83-91 2 Pollock WK, MacIntyre DE. Desensitization and antagonism of vasopressin-induced phosphoinositide metabolism and elevation of cytosolic free calcium concentration in human platelets. Biochem J 1986; 234: 67-73 3 Erne P, Pletscher A. Vasopressin-induced activation of human blood platelets: prominent role of Mg2+ . Naunyn-Schmiedeberg’s Arch Pharmacol 1985; 329: 97-99 4 Pletscher A, Erne P, Bürgisser E, Ferracin F. Activation of human blood platelets by arginine-vasopressin. Role of bivalent cations. Mol Pharmacol 1985; 28: 508-514 5 Berrettini WH, Post RM, Worthington EK, Casper JB. Human platelet vasopressin receptors. Life Sci 1982; 30: 425-432 6 Lapetina EG, Cuatrecasas P. Stimulation of phosphatidic acid production in platelets precedes the formation of arachidonate and parallels the release of serotonin. Biochim Biophys Acta 1979; 573: 394-402 7 Laubscher A, Pletscher A. Shape change and uptake of 5-hydroxy-tryptamine in human blood platelets: Action of neuropsychotropic drugs. Life Sci 1979; 24: 1833-1840 8 Michell RH. Inositol phospholipids and cell surface receptor function. Biochim Biophys Acta 1975; 415: 81-87 9 Lapetina EG. Metabolism of inositides and the activation of platelets. Life Sci 1983; 32: 2069-2082 10 Jolles J, Zwiers H, Dekker A, Wirtz KW A, Gispen WH. Corticotropin-(1-24)tetracosapeptide affects protein phosphorylation and polyphosphoinositide metabolism in rat brain. Biochem J 1981; 194: 283-291 11 Rittenhouse SE. Inositol lipid metabolism in the response of stimulated platelets. Cell Calcium 1982; 3: 311-322 12 Berridge MJ. Inositol triphosphate and diacylglycerol as second messengers. Biochem J 1984; 220: 345-360 13 Berridge MJ, Irvine RF. Inositol triphosphate, a novel second messenger in cellular transduction. Nature 1984; 312: 315-321